SCHEMBL733375

SCHEMBL733375

CCn1cc(C(O)(C(C)c2ccc(-c3ccc(C(=O)OC)c(OC)c3)cc2Cl)C(F)(F)F)ccc1=O

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.35
PDK2 Q15119 1/20 0.35
CHEK1 O14757 1/20 0.34
MAPT P10636 3/20 0.34
LMNA P02545 3/20 0.33
THRB P10828 1/20 0.33
KDM4E B2RXH2 3/20 0.33
PDE10A Q9Y233 3/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
HPGD P15428 3/20 0.33
ALDH1A1 P00352 3/20 0.33
NPY1R P25929 1/20 0.33
NPY2R P49146 1/20 0.33
RAB9A P51151 1/20 0.33
SOS1 Q07889 1/20 0.32
GAA P10253 1/20 0.32
HTT P42858 1/20 0.32
TP53 P04637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL753068 1.00 KMT2A (0.35) KMT2APDK2CHEK1MAPTLMNA
SCHEMBL754911 0.92 ESR1 (0.35) KMT2ACHEK1MAPTKDM4EPDE10A
SCHEMBL734058 0.92 ESR1 (0.35) KMT2ACHEK1MAPTKDM4EPDE10A
SCHEMBL754467 0.91 KDM4E (0.37) PDK2KDM4EPDE10A
SCHEMBL733615 0.91 KDM4E (0.37) PDK2KDM4EPDE10A
SCHEMBL754904 0.90 PDK2 (0.36) PDK2CHEK1MAPTLMNATHRB
SCHEMBL734838 0.90 PDK2 (0.36) PDK2CHEK1MAPTLMNATHRB
SCHEMBL15789745 0.88 KMT2A (0.39) KMT2AMAPTTHRBPDE10ASMN1; SMN2
SCHEMBL15789758 0.87 KMT2A (0.37) KMT2AMAPTLMNATHRBPDE10A
SCHEMBL15789720 0.84 KMT2A (0.34) KMT2AKDM4ESMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2411361-B1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN LA ROCHE (CH) 2014-06-18 EP claimed
US-8138189-B2 Substituted benzene compounds as modulators of the glucocorticoid receptor HOFFMAN-LA ROCHE INC. (US) 2012-03-20 US claimed
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-09-30 US claimed
EP-2411361-B1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN LA ROCHE (CH) 2014-06-18 EP disclosed
US-8138189-B2 Substituted benzene compounds as modulators of the glucocorticoid receptor HOFFMAN-LA ROCHE INC. (US) 2012-03-20 US disclosed
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS NR3C1, NR3C2, CRHR1 KMT2A 1893/4885PDK2 936/4885CHEK1 4597/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.